A Markov Chain approach for ranking treatments in network meta-analysis
View ORCID ProfileAnna Chaimani, Raphaël Porcher, Émilie Sbidian, Dimitris Mavridis
doi: https://doi.org/10.1101/19008722
Anna Chaimani
1Université de Paris, Research Center of Epidemiology and Statistics Sorbonne Paris Cité (CRESS-UMR1153), INSERM, INRA, F-75004 Paris, France
2Cochrane France, Paris, France
Raphaël Porcher
1Université de Paris, Research Center of Epidemiology and Statistics Sorbonne Paris Cité (CRESS-UMR1153), INSERM, INRA, F-75004 Paris, France
Émilie Sbidian
3Epidemiology in Dermatology and Evaluation of Therapeutics (EpiDermE) - EA 7379, Université Paris Est Créteil (UPEC), Créteil, France
Dimitris Mavridis
1Université de Paris, Research Center of Epidemiology and Statistics Sorbonne Paris Cité (CRESS-UMR1153), INSERM, INRA, F-75004 Paris, France
4Department of Primary Education, University of Ioannina, Ioannina, Greece

Data Availability
The data are available upon request.
Posted October 18, 2019.
A Markov Chain approach for ranking treatments in network meta-analysis
Anna Chaimani, Raphaël Porcher, Émilie Sbidian, Dimitris Mavridis
medRxiv 19008722; doi: https://doi.org/10.1101/19008722
Subject Area
Subject Areas
- Addiction Medicine (62)
- Allergy and Immunology (142)
- Anesthesia (44)
- Cardiovascular Medicine (408)
- Dermatology (47)
- Emergency Medicine (141)
- Epidemiology (4816)
- Gastroenterology (177)
- Geriatric Medicine (70)
- Health Economics (187)
- Health Informatics (621)
- Health Policy (314)
- Hematology (85)
- HIV/AIDS (155)
- Medical Education (91)
- Medical Ethics (24)
- Nephrology (73)
- Neurology (677)
- Nursing (41)
- Nutrition (112)
- Oncology (438)
- Ophthalmology (138)
- Orthopedics (36)
- Otolaryngology (88)
- Pain Medicine (35)
- Palliative Medicine (15)
- Pathology (128)
- Pediatrics (193)
- Public and Global Health (1800)
- Radiology and Imaging (321)
- Respiratory Medicine (255)
- Rheumatology (86)
- Sports Medicine (61)
- Surgery (100)
- Toxicology (23)
- Transplantation (28)
- Urology (37)